HIMS Stock Craters – Is It a Buying Opportunity?

Shares of Hims & Hers Health (NASDAQ:HIMS) continued to meltdown Tuesday in noontime trading after the direct-to-consumer healthcare platform said it couldn’t guarantee it would be able to continue selling its knockoff versions of weight-loss drugs Ozempic and Wegovy. Despite reporting strong fourth-quarter and full-year 2024 results, an announcement last week by the Food & […]